Howard, A. (2013), ‘The letting go, the building up [and] the gradual process of rebuilding: Identity change and post-traumatic growth in myalgic encephalomyelitis/chronic fatigue syndrome’: www.tandfonline.com/doi/full/ 10.1080/08870446.2012.721882.
2. Arroll, M.A. and Howard, A. (2012), ‘A preliminary prospective study of nutritional, psychological and combined therapies for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in a private care setting’: www.ncbi.nlm.nih.gov/ pubmed/23166120.
3. Arroll, M.A., et al. (2014), ‘Pilot study investigating the utility of a specialized online symptom management program for individuals with myalgic encephalomyelitis/chronic fatigue syndrome as compared to an online meditation program’: www.dovepress.com/pilot-studyinvestigating-the-utility-of-a-specialized-online- symptom-peerreviewed-article-PRBM.
Глава 2. Почему проблема усталости ставит конвенциональную медицину в тупик
4. Wortman, M.S.H., et al. (2018), ‘Cost-effectiveness of interventions for medically unexplained symptoms: A systematic review’: www.ncbi.nlm.nih.gov/pmc/articles/ PMC6188754/.
5. Burton, C. (2003), ‘Beyond somatisation: a review of the understanding and treatment of medically unexplained physical symptoms (MUPS)’: www.ncbi.nlm.nih.gov/pmc/articles/PMC1314551/.
6. The Medical Staff of the Royal Free Hospital (1957), ‘An outbreak of encephalomyelitis in the Royal Free Hospital Group, London, in 1955’: www.ncbi.nlm.nih.gov/pubmed/13472002.
7. Ramsay, A.M. (1965), ‘Hysteria and “Royal Free Disease”’: www.ncbi.nlm.nih.gov/pmc/articles/PMC1847119/?page=1.
8. Ramsay, A.M., et al. (1977), ‘Icelandic disease (benign myalgic encephalomyelitis or Royal Free disease)’: www.ncbi.nlm.nih.gov/pubmed/861618.
9. Ramsay, A.M. (1978), ‘Epidemic neuromyasthenia 1955–1978’: www.ncbi.nlm.nih.gov/pubmed/746017.
10. Pasteur (1881), ‘On the Germ Theory’: www.ncbi.nlm.nih.gov/pubmed/17830637.
11. Smith, K.A. (2012), ‘Louis Pasteur, the father of immunology?’: www.ncbi.nlm.nih.gov/pubmed/22566949.
12. Cortes Rivera, M., et al. (2019), ‘Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review’: www.ncbi.nlm.nih.gov/pubmed/31394725.
13. Sweetman, E., et al. (2019), ‘Current Research Provides Insight into the Biological Basis and Diagnostic Potential for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)’: www.ncbi.nlm.nih.gov/pubmed/31295930.
14. Underhill, R.A. (2015), ‘Myalgic encephalomyelitis, chronic fatigue syndrome: An infectious disease’: http://dx.doi.org/10.1016/j.mehy.2015.10.011.
15. Rowe, P.C., et al. (2017), ‘Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer’: www.ncbi.nlm.nih.gov/pubmed/28674681.
16. McEvedy, C.P. and Beard, A.W. (1970), ‘Concept of benign myalgic encephalomyelitis’: www.ncbi.nlm.nih.gov/pubmed/5411596.
17. McManimen, S., et al. (2019), ‘Dismissing chronic illness: A qualitative analysis of negative health care experiences’: www.ncbi.nlm.nih.gov/pubmed/30829147.
18. Friedman, K.J. (2019), ‘Advances in ME/CFS: Past, Present, and Future’: www.ncbi.nlm.nih.gov/pubmed/31058116.
19. Centers for Disease Control and Prevention (2020), ‘Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)’: www.cdc.gov/me-cfs/index.html.
20. Raine, R., et al. (2004), ‘General practitioners’ perceptions of chronic fatigue syndrome and beliefs about its management, compared with irritable bowel syndrome: qualitative study’: www.ncbi.nlm.nih.gov/pmc/articles/PMC420289/.
21. Lian, O.S. and Robson, C. (2017), ‘“It’s incredible how much I’ve had to fight”’; negotiating medical uncertainty in clinical encounters’: www.ncbi.nlm.nih.gov/pubmed/29063801.
22. Collin, S.M. and Crawley, E. (2017), ‘Specialist treatment of chronic fatigue syndrome/ME: a cohort study among adult patients in England’: www.ncbi.nlm.nih.gov/pubmed/28709432.
23. Maizes, V., etal. (2009), ‘Integrative Medicine and Patient-Centered Care’: www.sciencedirect.com/science/article/abs/pii/S1550830709002341?via%3Dihub.
24. Ali, A. and Katz, D.L. (2015), ‘Disease Prevention and Health Promotion: How Integrative Medicine Fits’: www.ncbi.nlm.nih.gov/pubmed/26477898.
25. Bland, J. (2015), ‘Functional Medicine: An Operating System for Integrative Medicine’: http://www.ncbi.nlm.nih.gov/pubmed/26770161.
26. National Institute of Clinical Excellence (NICE) (2007), ‘Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): diagnosis and management of chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy) in adults and children’: http://guidance.nice.org.uk/CG53/Guidance/pdf/English.
27. Baker, R. and Shaw, E.J. (2007), ‘Guidelines: Diagnosis and management of chronic fatigue syndrome or myalgic encephalomyelitis (or encephalopathy): Summary of NICE guidance’, British Medical Journal, 335(7617): 446–8.
28. Jones, J.F. et al. (2009), ‘An evaluation of exclusionary medical/psychiatric conditions in the definition of chronic fatigue syndrome’: https://pubmed.ncbi.nlm.nih.gov/19818157/.
29. Fukuda, K. et al. (1994), ‘The chronic fatigue syndrome: a comprehensive approach to its definition and study’: www.ncbi.nlm.nih.gov/pubmed/7978722.
30. Brurberg, K.G. et al. (2014), ‘Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review’: www.ncbi.nlm.nih.gov/pubmed/24508851.
31. Brimmer, D.J. et al. (2013), ‘A pilot registry of unexplained fatiguing illnesses and chronic fatigue syndrome’: www.ncbi.nlm.nih.gov/pubmed/23915640.
32. Bansal, A.S. (2016), ‘Investigating unexplained fatigue in general practice with a particular focus on CFS/ME’: www.ncbi.nlm.nih.gov/pubmed/27436349.
33. Strand, E.B. et al. (2019), ‘Myalgic encephalomyelitis/chronic fatigue Syndrome (ME/CFS): Investigating care practices pointed out to disparities in diagnosis and treatment across European Union’: www.ncbi.nlm.nih.gov/pubmed/31805176.
34. Cohen, H. (2017), ‘Controversies and challenges in fibromyalgia: a review and a proposal’: www.ncbi.nlm.nih.gov/pubmed/28458723.
35. Arnold, L.M. et al. (2016), ‘Fibromyalgia and Chronic Pain Syndromes: A White Paper Detailing Current Challenges in the Field’: www.ncbi.nlm.nih.gov/pubmed/ 27022674.
36. Garcia-Monco, J.C. and Benach, J.L. (2019), ‘Lyme Neuroborreliosis: Clinical Outcomes, Controversy, Pathogenesis, and Polymicrobial Infections’: www.ncbi.nlm.nih.gov/pubmed/30536421.
37. Jaulhac, B., et al. (2019), ‘Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies (II). Biological diagnosis, treatment, persistent symptoms after documented or suspected Lyme borreliosis’: www.sciencedirect.com/science/article/pii/S0399077X19301313?via%3Dihub.
38. Rauer, S., et al. (2018), ‘Lyme Neuroborreliosis’: www.ncbi.nlm.nih.gov/pubmed/ 30573008.
39. Baker, P.J. (2020), ‘A Review of Antibiotic-Tolerant Persisters and Their Relevance to Post-treatment Lyme Disease Symptoms’: www.ncbi.nlm.nih.gov/pubmed/ 31926865.
Глава 3. Как ваше тело создает энергию
40. Morris, G. and Maes, M. (2014), ‘Mitochondrial dysfunctions in Myalgic Encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways’, Metabolic Brain Disease, 29(1): 19–36.
41. Zare˛bska, A.E., et al. (2018), ‘Plasma Nucleotide Dynamics during Exercise and Recovery in Highly Trained Athletes and Recreationally Active Individuals’: www.hindawi.com/journals/bmri/2018/4081802.
42. Nacul, L., et al. (2019), ‘Evidence of Clinical Pathology Abnormalities in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) from an Analytic CrossSectional Study’: www.ncbi.nlm.nih.gov/pubmed/30974900.
43. Twisk, F.N.M. (2015), ‘Accurate diagnosis of myalgic encephalomyelitis and chronic fatigue syndrome based upon objective test methods for characteristic symptoms’: www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4482824&tool=pmcentrez&rendertype=abstract.
44. VanNess, J.M., et al. (2010), ‘Postexertional Malaise in Women with Chronic Fatigue Syndrome’: www.liebertpub.com/doi/10.1089/jwh.2009.1507.
45. Holtzman, C., et al. (2019), ‘Assessment of Post-Exertional Malaise (PEM) in Patients with Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS): A Patient-Driven Survey’: www.mdpi.com/2075-4418/9/1/26.
46. Bou-Holaigah, I. (1995), ‘The Relationship Between Neurally Mediated Hypotension and the Chronic Fatigue Syndrome’: http://jama.jamanetwork.com/article.aspx?articleid=389684.
47. Ocon, A.J., et al. (2012), ‘Increasing orthostatic stress impairs neurocognitive functioning in chronic fatigue syndrome with postural tachycardia syndrome’: www.ncbi.nlm.nih.gov/pubmed/21919887.
48. Chu, L., et al. (2018), ‘Deconstructing post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: A patient-centered, crosssectional survey’: www.ncbi.nlm.nih.gov/pubmed/29856774.
49. Arroll, M.A., et al. (2014), ‘The delayed fatigue effect in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)’: www.tandfonline.com/doi/abs/10.1080/21641846.2014.892755.
50. Cvejic, E., et al. (2017), ‘Autonomic nervous system function, activity patterns, and sleep after physical or cognitive challenge in people with chronic fatigue syndrome’: www.ncbi.nlm.nih.gov/pubmed/29167053.
51. Nijs, J., et al. (2012), ‘In the mind or in the brain? Scientific evidence for central sensitisation in chronic fatigue syndrome’: www.ncbi.nlm.nih.gov/pubmed/21793823.
52. Myhill, S., et al. (2009), ‘Chronic fatigue syndrome and mitochondrial dysfunction’: www.ncbi.nlm.nih.gov/pmc/articles/PMC2680051/.
53. Booth, N.E., et al. (2012), ‘Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)’: www.ncbi.nlm.nih.gov/pubmed/22837795.
54. Nicolson, G.L. (2014), ‘Mitochondrial dysfunction and chronic disease: Treatment
